[go: up one dir, main page]

Chen, 2010 - Google Patents

Proteomic dissection of biological pathways/processes through profiling protein-protein interaction networks

Chen, 2010

Document ID
2382800728112743840
Author
Chen X
Publication year
Publication venue
Science China Chemistry

External Links

Snippet

Cellular functions, either under the normal or pathological conditions or under different stresses, are the results of the coordinated action of multiple proteins interacting in macromolecular complexes or assemblies. The precise determination of the specific …
Continue reading at link.springer.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used

Similar Documents

Publication Publication Date Title
Fabre et al. Deciphering preferential interactions within supramolecular protein complexes: the proteasome case
Schulze et al. A novel proteomic screen for peptide-protein interactions
Bausch-Fluck et al. A mass spectrometric-derived cell surface protein atlas
Robinson et al. Molecular architecture of the yeast Mediator complex
Ardeljan et al. LINE-1 ORF2p expression is nearly imperceptible in human cancers
Bonfiglio et al. Serine ADP-ribosylation depends on HPF1
Klaeger et al. Optimized liquid and gas phase fractionation increases HLA-peptidome coverage for primary cell and tissue samples
Mak et al. A lentiviral functional proteomics approach identifies chromatin remodeling complexes important for the induction of pluripotency
Chapman et al. Mapping PARP-1 auto-ADP-ribosylation sites by liquid chromatography–tandem mass spectrometry
Cantin et al. Quantitative phosphoproteomic analysis of the tumor necrosis factor pathway
Petkowski et al. Substrate specificity of mammalian N-terminal α-amino methyltransferase NRMT
Kotliński et al. Histone H1 variants in Arabidopsis are subject to numerous post-translational modifications, both conserved and previously unknown in histones, suggesting complex functions of H1 in plants
Völkel et al. Interaction proteomics: characterization of protein complexes using tandem affinity purification–mass spectrometry
Wang et al. In vivo dual-tagging proteomic approach in studying signaling pathways in immune response
Byron et al. Characterisation of a nucleo-adhesome
Oellerich et al. SLP-65 phosphorylation dynamics reveals a functional basis for signal integration by receptor-proximal adaptor proteins
Figeys Peer Reviewed: Prometrics Approaches in Drug Discovery
Finton et al. ARTEMIS: A novel mass-spec platform for HLA-restricted self and disease-associated peptide discovery
Banks et al. Controlling for gene expression changes in transcription factor protein networks
Zhang et al. A proteome‐scale study on in vivo protein Nα‐acetylation using an optimized method
Lim Kam Sian et al. SAPrIm, a semi-automated protocol for mid-throughput immunopeptidomics
Jensen Modification-specific proteomics: systematic strategies for analysing post-translationally modified proteins
Alagesan et al. Improved N-and O-glycopeptide identification using high-field asymmetric waveform ion mobility spectrometry (FAIMS)
Dan et al. A cell-free system toward deciphering the post-translational modification barcodes of Oct4 in different cellular contexts
Zee et al. Quantitative proteomic approaches to studying histone modifications